InvestorsHub Logo
Followers 37
Posts 2569
Boards Moderated 0
Alias Born 12/21/2014

Re: None

Wednesday, 11/18/2015 4:37:42 AM

Wednesday, November 18, 2015 4:37:42 AM

Post# of 87250
The FDA Regulation being reviewed in the next 90 days is the nice to have basket for clarity on how this will this impact FIN brand in the US. The growth engine of ECIG though is the VIP brand which is UK based and has nothing to do with FDA in the USA and is where all the growth is and revenues are for ECIG. All I can see is that we are expanding at a rapid rate in the UK and Europe where the public appear to be more aware when it comes to ECIG usage compared to the US through reports like the public health England study stating 95% less harmful then regular cigarettes and so on.

ECIG is really more a European company operationally speaking being listed in the USA. It is up to Dan and the team to educate the investment community in the USA about where the company sells their products and where they are expanding so there is no misconceptions with all the USA FDA regulations and misinformation regarding ECIGs there. It would be nice if they took a more proactive approach in this area over the next couple of weeks before the year ends. All IMHO do your own dd.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.